PrimeRFP SCOUT · Federal Contract Recompete Brief

36C77021N0219Pharmaceutical - valbenazine 80mg ORAL capsules — Neurocrine Biosciences, Inc

The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Sep 15, 2021 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

National Cmop Office (36C770)

Awarding office

Neurocrine Biosciences, Inc

Recipient

Sep 15, 2021

PoP end

$675K

Obligated

$675K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Neurocrine Biosciences, Inc — $90

Contract facts

Federal

Contract number36C77021N0219

Also listed as36C770-21-N-0219

Also listed as36F79718D0414-36C77021N0219

AgencyNational Cmop Office (36C770)

Awarding officeNational Cmop Office (36C770)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentNeurocrine Biosciences, Inc

CAGE5H9C3

UEIGMQSH4CZ7EC9

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79718D0414

Place of performanceSAN DIEGO CA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startSep 10, 2021

PoP end (current)Sep 15, 2021

Obligated$675K

Current value$675K

Potential value$675K

PHARMACEUTICAL - VALBENAZINE 80MG ORAL CAPSULES FOR HINES CMOP is a federal award for National Cmop Office (36C770) held by Neurocrine Biosciences, Inc. Estimated value $675K ($675K obligated). Current period of performance ends Sep 15, 2021. Last award drew 1 bidder. Place of performance: SAN DIEGO CA.

PHARMACEUTICAL - VALBENAZINE 80MG ORAL CAPSULES FOR HINES CMOP

Recompete timing

Public

● Past PoP end (1801 days ago)

Current PoP ended Sep 15, 2021 (1801 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C77021N0219?

36C77021N0219 (Pharmaceutical - valbenazine 80mg ORAL capsules) is a National Cmop Office (36C770) award with a potential value of $675K, currently held by Neurocrine Biosciences, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C770-21-N-0219?

36C770-21-N-0219 is the dashed form of PIID 36C77021N0219 (Pharmaceutical - valbenazine 80mg ORAL capsules), held by Neurocrine Biosciences, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C77021N0219?

National Cmop Office (36C770) awarded 36C77021N0219 to Neurocrine Biosciences, Inc (potential $675K).

Who is the incumbent on 36C77021N0219?

Neurocrine Biosciences, Inc is the incumbent. The current period of performance ends Sep 15, 2021.

When does Neurocrine Biosciences, Inc’s 36C77021N0219 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 15, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Sep 10, 2021 · refreshed monthly